default author photo

Shengyun Liu

Zhengzhou University - First Affiliated Hospital

Zhengzhou

China

SCHOLARLY PAPERS

2

DOWNLOADS

159

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Efficacy and Safety of Mufemilast in Patients with Behçet's Syndrome: A Phase 2, Double-Blind, Placebo-Controlled Trial

Number of pages: 30 Posted: 10 Mar 2025
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Tongji University, Wenzhou Medical University, Xiamen University, Xuzhou Medical University, Xuzhou Medical University, Peking University - Department of Rheumatology and Clinical Immunology, Government of the People's Republic of China - Beijing Hospital, Sun Yat-sen University (SYSU) - Department of Rheumatology, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, Zhejiang University, Zhejiang University, People's Hospital of Xinjiang Uygur Autonomous Region, Shandong University - Linyi People's Hospital, Zhengzhou University - First Affiliated Hospital, Anhui Provincial Hospital, Fudan University - Zhongshan Hospital, Soochow University, Capital Medical University, Jilin Province People’s Hospital, Jilin Province People’s Hospital, The University of Hong Kong - Shenzhen Hospital, Baotou Medical College - First Affiliated Hospital, Fudan University, Fudan University, Nanjing Medical University - Jiangsu Province Hospital, Jilin University, Pingxiang People's Hospital, Hangzhou Medical College - Zhejiang Provincial People's Hospital, Chengdu Medical College, Ganzhou Hemay Pharmaceutical Co., Ltd, Ganzhou Hemay Pharmaceutical Co., Ltd and Peking University - Department of Rheumatology and Immunology
Downloads 117 (645,052)

Abstract:

Loading...

Phosphodiesterase 4 inhibitor, Behçet's syndrome, Mufemilast, RCT

2.

A Randomized, Double-Blind, Phase III Study to Compare the Efficacy and Safety of GB242 and Infliximab When Administered with Methotrexate in Patients with Active Moderate to Severe Rheumatoid Arthritis

Number of pages: 33 Posted: 31 Mar 2021
Peking University - Department of Rheumatology and Immunology, Zhengzhou University - First Affiliated Hospital, Xuzhou General Hospital -Department of Rheumatology and Immunology, First Hospital of Qiqihar, Jiujiang No.1 People's Hospital - Department of Rheumatology and Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Shanxi Medical University - First Hospital, The People’s Hospital of Xin Jiang Uygur Autonomous Region - Department of Rheumatology and Immunology, Bengbu Medical College - First Affiliated Hospital, Zaozhuang Municipal Hospital - Department of Rheumatology and Immunology, Xinjiang Medical University - First Affiliated Hospital, People’s Hospital of Guangxi Zhuang Autonomous Region, Inner Mongolia University, Jilin University (JLU) - First Affiliated Hospital, Soochow University - First Affiliated Hospital, Inner Mongolia University of Science and Technology, Shandong First Medical University - Shandong Provincial Hospital, University of Science and Technology of China (USTC) - Anhui Provincial Hospital, Sun Yat-sen University (SYSU) - School of Medicine, Qinghai University - Qinghai University Affiliated Hospital, Yangzhou University - Northern Jiangsu People's Hospital, Nantong University - Affiliated Hospital, Guangxi Medical University - Fifth Affiliated Hospital, Sun Yat-sen University (SYSU) - Department of Rheumatology, Nanchang University - Jiangxi Provincial People’s Hospital, Xiamen University - Department of Rheumatology and Clinical Immunology, Shandong University - Linyi People's Hospital, Peking University - Beijing Jishuitan Hospital, Genor Biopharma Co., Ltd. - Department of Biometrics, Genor Biopharma Co., Ltd. - Department of Biometrics and Peking University - Department of Rheumatology and Immunology
Downloads 42 (1,170,409)

Abstract:

Loading...

rheumatoid arthritis; infliximab; biosimilar